VerLys: The Impact of Milk Protein Glycation on Protein Digestion and Absorption
Study Details
Study Description
Brief Summary
Rationale: Protein intake is an essential stimulus for muscle protein anabolism. The muscle protein synthetic response to protein ingestion is mainly determined by the post-prandial plasma amino acid response. Milk protein often undergoes glycation during commonly applied milk processing procedures (Maillard reaction). We have previously shown that glycated protein results in lower postprandial amino acid levels. The level of protein glycation in processed dairy products might therefore be an important modulator of the overall protein quality of a product, and its ability to stimulate protein metabolism. However, it has not yet been investigated if the glycation level of dietary protein modulates its appearance in plasma as amino acids.
Objective: To compare the appearance of dietary protein-derived amino acids in plasma after ingestion of a milk protein powder with different levels of protein glycation in healthy young men.
Study design: Double blinded, randomized cross-over study. Study population: 15 healthy young males, aged 18-35 years. Intervention (if applicable): All subjects will perform two experiments in a double-blinded, randomized order: ingest 40 g of milk protein with 5% glycation level in 600 mL water, or 40 g of milk protein with 50% glycation level in 600 mL water. After ingestion, blood samples will be taken at regular intervals during a 6 hour period.
Main study parameters/endpoints: The primary endpoint will be the appearance of milk protein-derived amino acids in plasma over the full assessment period (6 h), as determined using stable isotope tracer methodology.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Proteins are mainly required as building blocks for muscle maintenance and muscle growth. To supply these building blocks for growth and development, proteins need to be well digested, and absorbed in the circulation.
Processing of milk to produce dairy products, such as milk protein powders, may affect protein quality. Heat processes can impact native protein structure, for example by inducing protein denaturation and aggregation. In addition, reducing sugars such as lactose can react with the amino group of amino acids, known as the Maillard reaction or protein glycation. Glycation levels in milk protein powders can range from 5-50%, depending on factors such as water content and storage temperature.
Several in vitro and animal studies have shown that protein glycation decreases protein digestibility. In addition, we have recently demonstrated that protein glycation reduces post-prandial amino acid availability in humans. This reduced postprandial amino acid availability could mostly be attributed to a reduction in postprandial availability of the essential amino acid lysine. The lower post-prandial availability of amino acids following ingestion of protein with a high glycation level suggests an impaired digestion and absorption of glycated dietary protein.
Therefore, to test whether ingestion of a high glycated milk protein results in a lower appearance of dietary protein-derived amino acids, a human trial has been designed. Subjects will consume a low or high glycated milk protein drink, where after several blood samples will be taken to assess the appearance of dietary protein-derived amino acids over time by using a continuous amino acid tracer infusion. The low and high glycated protein drinks reflect the lower and upper range of protein glycation reported in dairy protein products. We hypothesize that protein glycation attenuates the appearance of dietary protein-derived amino acids in plasma.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Low glycated milk protein 40 grams of low glycated milk protein, blocked lysine level ~5% |
Dietary Supplement: Low glycated milk protein
40 grams of protein dissolved in 600 mL of water
|
| Experimental: High glycated milk protein 40 grams of high glycated milk protein, blocked lysine level ~50% |
Dietary Supplement: High glycated milk protein
40 grams of protein dissolved in 600 mL of water
|
Outcome Measures
Primary Outcome Measures
- Plasma appearance of dietary amino acids [0-6 hours]
Appearance of milk protein-derived amino acids in plasma over the full assessment period (6 h), as determined using stable isotope tracer methodology
Secondary Outcome Measures
- Whole-body protein kinetics [0-6 hours]
total rate of appearance, exogenous rate of appearance, endogenous rate of appearance, rate of disappearance
- Whole body protein metabolism [0-6 hours]
Protein synthesis, breakdown, oxidation, and net balance
- Peak plasma lysine concentration [0-6 hours]
Maximum plasma lysine concentration
- Overall plasma amino acid responses [0-6 hours]
Plasma amino acid concentration before and after intake of the drink
- Plasma glucose concentrations [0-6 hours]
Plasma glucose concentrations
- Plasma insulin concentrations [0-6 hours]
Plasma insulin concentrations
Other Outcome Measures
- Age [Baseline]
Age in years
- Body weight [Baseline]
Body weight in kg
- Body length [Baseline]
Body length in cm
- BMI [Baseline]
BMI in kg/m^2, calculated from weight and length
- Fat mass [Baseline]
Fat mass in kg.
- Fat percentage [Baseline]
Fat mass in fat percentage, calculated using fat mass & body weight in kg.
- Lean body mass [Baseline]
Lean body mass in kg.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Males
-
Aged between 18-35 years
-
Healthy, recreationally active (participating in recreational sports activities ≥ 1 and ≤ 6 h per week, with a maximum of 2 h resistance-type exercise)
-
18.5 ≤ BMI ≤ 30 kg/m2
-
No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).
Exclusion Criteria:
-
Smoking
-
Lactose intolerant or allergies to milk proteins
-
Musculoskeletal disorders
-
Metabolic disorders
-
Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
-
Chronic use of gastric acid suppressing medication or anti-coagulants
-
Unstable weight over the last three months
-
Diagnosed GI tract disorders or diseases
-
Blood donation in the past 2 months
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Maastricht University Medical Center+ | Maastricht | Limburg | Netherlands | 6229ER |
Sponsors and Collaborators
- Maastricht University Medical Center
- FrieslandCampina
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- METC 22-004